期刊文献+

慢性炎症机制与多囊卵巢综合征 被引量:15

Chronic Inflammation With Polycystic Ovarian Syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是一种临床高度异质、病因复杂的疾病。近年研究发现,PCOS存在慢性炎症的病理生理过程,而且慢性炎症在PCOS远期并发症的发生发展中起重要作用。主要的慢性炎症因子,如C反应蛋白(CRP)、白细胞介素类(IL)、血浆纤溶酶原激活物抑制物1(PAI-1)、单核细胞趋化因子1(MCF-1)、肿瘤坏死因子(TNF)等在PCOS患者中有不同程度的升高,并且与PCOS患者的胰岛素抵抗、心血管疾病发病风险增高密切相关。 PCOS is a heterogeneous and complicated disease.Recently,it has been demonstrated that chronic inflammation participates in the pathphysiological progress of PCOS,which is closely related with the initiation and progression of long-term complications of PCOS.The elevated levels of main chronic inflammatory cytokines,including C-reactive protein(CRP),Interleukins(IL),Plasminogen Activator Inhibitor-1(PAI-1),Monocyte Chemotactic Factor-1(MCF-1) and Tumor Necrosis Factor(TNF),are associated with insulin resistance and cardiovascular diseases in women with PCOS.
出处 《国际妇产科学杂志》 CAS 2010年第6期380-382,393,共4页 Journal of International Obstetrics and Gynecology
关键词 多囊卵巢综合征 炎症 胰岛素抗药性 心血管疾病 C反应蛋白质 Polycystic ovarian syndrome Inflammation Insulin resistance Cardiovascular diseases C-reactive protein
  • 相关文献

参考文献2

二级参考文献29

  • 1胡振兴,乔杰,李美芝,张小为,陈咏健,李蓉,孙春玲.多囊卵巢综合征相关基因的差异表达研究[J].北京大学学报(医学版),2004,36(6):600-604. 被引量:25
  • 2赵君利,陈子江,赵跃然,赵力新,王来成,唐蓉,马增香.纤溶酶原激活物抑制因子1基因启动子区4G和5G多态基因型分布及其与多囊卵巢综合征的相关性研究[J].中华妇产科杂志,2005,40(8):528-531. 被引量:17
  • 3李秀均.胰岛素抵抗综合征(第1版)[M].北京:人民卫生出版社,2001,1.86. 被引量:5
  • 4Legro RS,Kunselman AR,Dodson WC,et al.Prevalence and predictors of risk for type 2 diabetes rnellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective,controlled study in 254 affected women.AJ Clin Endocrinol Metab,1999,84(1):165 ~ 169. 被引量:1
  • 5Atiomo WU,Bates SA,Condon JE,et al.The plasminogen activator system in women with polycystic ovary syndrome.Fertil Steril,1998,69(2):236 ~ 241. 被引量:1
  • 6Diamanti-Kandarakis E,Palioniko G,Alexandraki K,et al.The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.Eur J Endocrinol,2004,150(6):793 ~ 798. 被引量:1
  • 7Orio F Jr,Palomba S,Cascella T,et al.Plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?Reprod Biomed Online,2004,9 (5):505 ~ 510. 被引量:1
  • 8The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.FERTILITY and STERILITY,2004,81(1)19~25. 被引量:1
  • 9Tarkun I,Canturk Z,Arslan BC,et al.The plasminogen activator system in young and lean women with polycystic ovary syndrome.Endocr J,2004,51(5):467 ~ 472. 被引量:1
  • 10Sampson M,Kong C,Patel A,et al.Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.Clin Endocrinol (Oxf),1996,45(5):623 ~ 629. 被引量:1

共引文献8

同被引文献180

引证文献15

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部